Fig. 1From: A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy – including photon and proton therapy – for the treatment of radioresistant tumors: the ETOILE trialChoice between photon and proton therapy in the control arm. ΔNTCP, Difference in normal tissue complication probability; LOAR, Dose limits of organs at risk; OAR, Organs at risk; RD, Recommended dosesBack to article page